[Current possibilities of surgical and combined treatment of patients with uterine cancer].
Surgical treatment alone was given to 88 patients with endometrial tumors while 182 patients underwent combined therapy. Three-year survival was 92.1%: 88.5% survived 5 years. With tumor invasion depth down to 10 mm, the method of choice was surgery: 5-year survival rate--89.1%. Postoperative irradiation of the small pelvis was indicated in cases of deep invasion of more than 10 mm. 5-year survival after surgery was 66.7 and combined therapy--76.7%. The end results appeared to depend on site: on sites in the upper two-thirds of the endometrium, 5-year survival after surgery was 90.4%; combined treatment of tumor sitting in the lower third or cervical canal--66.6 and 60.9%, respectively.
Mar'ina
L A
LA
N.N. Blokhin Center for Cancer Research, Russian Academy of Medical Sciences, Moscow.
Kazachenko
V P
VP
Nechushkin
M I
MI
D000230:Adenocarcinoma / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery*; D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D011182:Postoperative Care; D013997:Time Factors; D014594:Uterine Neoplasms / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery*